Bowel Cancer and Biomarker Research Lab
Bowel cancer, also known as colorectal cancer, is the second most common cancer in Australian men and women. It affects 1 in 13 people. It is also Australia’s second deadliest cancer, with over 5,000 people dying each year. Early detection through screening can improve survival rates, however further research is needed to help find cures and prevent the disease.
The Bowel Cancer and Biomarker Laboratory at the Kolling Institute uses advanced technologies to study the genes and proteins responsible for bowel cancers growing and spreading. Our aim is to use a patient’s own molecular information to understand the risk of bowel cancer developing and to guide treatment options. As part of our research, we are studying how to control bowel polyp growth, which are precursors to cancer. We are doing this through diet and chemotherapy drugs.
Prof Mark P. Molloy, PhD | Lawrence Penn Chair of Bowel Cancer Research
The University of Sydney | Northern Clinical School
Faculty of Medicine and Health
Honorary Professor | Dept. Molecular Sciences, Macquarie University
Secretary | Australasian Proteomics Society
Dr Jun Li PhD
Postdoctoral Research Fellow
Dr Binh Pham, PhD
Postdoctoral Scientist
Dr Benita Tse
Postdoctoral Scientist
Matthew McKay - Senior Research Officer
Current bowel cancer research focuses on:
- Why and how some bowel polyps become cancers
- Which bowel tumours are likely to spread
- Molecular make-up of colorectal tumours
- Early detection of disease recurrence
Our research is facilitated by specimens from clinical projects we run including:
- Sydney 1000 bowel cancer study
- IMAP Bowel polyp study
Bowel Cancer and Biomarker Research related information
Events, News and Seminars
First Australian imaging technology to deliver research windfall
Posted on: 07 May, 2021
An exciting project between the University of Sydney and the Northern Sydney Local Health District ..... Read more
Category: World-leading technology
Cancer expertise recognised
Posted on: 10 December, 2020
The Kolling’s Dr Amanda Hudson will lead an exciting pilot study after being awarded an innovation g..... Read more
Category: Funding support, Neuroscience and Pain Research
New funding launches exciting project to detect cancer earlier
Posted on: 10 December, 2020
Congratulations to Kolling cancer researcher and Sydney Vital fellow Dr Yaser Hadi Gholami on being ..... Read more
Category: Funding support